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Abstract
The definition of the “atopic state”, i.e. subjects presenting at least one skin wheal with a minimum diameter of 3
mm induced by an allergen skin-prick test (ASPT), is based on the assumption that wheal size depends entirely on
the amount of histamine produced in the antigen-antibody reaction. Several epidemiological studies have, however,
demonstrated that an ASPT-elicited wheal is heavily modulated by “histamine skin reactivity” (HSR), i.e. the size of
the wheal induced by a prick test performed with a given solution of histamine. HSR not only varies widely
depending on the individual characteristics and geographical setting, but also changes over time; these differences
in HSR markedly influence the amount of specific IgE required to produce a wheal of at least 3 mm in an ASPT. We
should therefore ideally conceive the existence of two types of” atopic patients”: one type in whom “atopy” is mainly
the result of an increased level of specific IgE antibodies, and another type in whom positive ASPTs are mainly the
result of marked skin reactivity to even small amounts of histamine. If hyper-reactivity to histamine occurs not only in
the skin but in parallel also in other parts of the organism, especially at the mucosal level, “normal” histamine
production may cause chronic or recurrent clinical symptoms.
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Background
An atopic state in a subject is defined as a skin wheal of at least 3
mm in diameter elicited by an allergen skin prick test (ASPT)
performed with common environmental allergens (Dermatophagoides,
pollens, cat, etc.) [1,2].
The 3 mm threshold of significance of the wheal is a mere
convention adopted for practical purposes: a 4-10 mm wheal
characterizes highly atopic subjects, while a 1-2 mm wheal shows a low
tendency or predisposition to produce specific IgE, in a continuum
which is the rule in biological phenomena.
The definition of the level of atopy by means of ASPTs is based on
the assumption that the size of the wheal observed after the epi-
cutaneous injection of an allergen depends exclusively on the amount
of histamine that is produced in the antigen-antibody (Ag-Ab)
reaction [3]. This assumption would be true if, and only if, “histamine
skin reactivity” (HSR) i.e. the size of the wheal produced by a prick test
performed with a given solution of histamine (e.g. 10 mg/ml) were the
same in different people, regardless of age, geographical settings, etc.
Several epidemiological data have demonstrated that this is not the
case. First of all, individual HSR values in the numerous population
studies are fairly evenly spread on either side of the mean (plus or
minus 20-30 %) [4-9]. Moreover, in a number of epidemiological
studies, HSR varied significantly in different populations [10-12], and
was even found to increase over time within the same geographical
setting [5,6]. To what extent HSR variability affects the results of the
ASPT has not been previously discussed in any depth and is virtually
ignored in various “official position papers” on skin prick testing where
histamine is often vaguely treated as the “positive control” [1]. This gap
in our knowledge needs to be filled and the consequences at the
epidemiological and clinical level of HSR variability on what we define
as “atopy” deserve a full and exhaustive discussion.
Histamine Wheal
Histamine is synthesized above all by mast cells, and when released
it causes smooth muscle cell contraction, vasodilatation, increased
vascular permeability, inter-cell neurotransmission and nociceptive
nerve fiber stimulation. These are some of the numerous pathways that
contribute to the formation of a local skin wheal in the presence of
histamine, regardless of whether this mediator is released as a
consequence of a local Ag-Ab reaction (specific IgE antibodies bound
to cell membrane cross-links with specific allergens) or is directly
injected in the skin. Histamine is metabolized by a deamino-oxidase
(DAO, former name: histaminase) that is stored in epithelial cells and
is the main factor underlying the balance between histamine
production and degradation. A delay in histamine degradation due to
impaired enzymatic DAO function has been reported: the defect may
be caused by either genetic or acquired (in most cases reversible)
factors [13]. Various single-nucleotide polymorphisms in the human
DAO gene, located on chromosome 7q35, are associated with clinical
conditions, such as food allergies, and represent a potential genetic
background of a reduced or accelerated histamine metabolism [14-16].
A peculiar and interesting case is the rare and complex McCune-
Albright syndrome, which is characterized by precocious puberty and
café-au-lait spots and is caused by a genetic mutation encoding a
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stimulatory G protein (G5alpha): all the patients with the syndrome
display marked skin reactivity to histamine [17].
Histamine Skin Reactivity in Epidemiology
Although the histamine prick test is highly reproducible in the same
patient [18], its inter-individual variability is considerable. In one large
epidemiological study [6], skin prick tests with a 10 mg/ml histamine
solution performed in unselected 9-year-old school children produced
a wheal with a 4.5-5.5 mm diameter and a standard deviation of
0.8-1.0 mm: the spread of values was such that there was a large
overlap in the size of wheals produced by a 1 mg/ml histamine solution
(30% of children were “low responders”). Similar results were obtained
by Scherer et al. [18] who, using a very precise technique for a
histamine intradermal skin test, found a high reproducibility in the
same individuals but a considerable inter-individual variability
(standard deviations of the order of 50% of the mean, with some
patients developing a wheal three times as large as other patients).
Similar results were obtained by Van Gysell et al. [8].
Histamine-induced skin wheals have been reported to be larger i) in
male than in female subjects in some studies [7] though not in others
[5,6,8], ii) in the upper back than in the arm [19], iii) in younger than
in older subjects [20] and iv) in subjects with higher body mass index
[21]. Lower HSR is reported to be associated with some environmental
factors, such as passive smoking exposure and sun-exposed skin areas
[9,22]. Many studies contain data that partially explain this biological
HSR variability: differences in “histamine releasability” from mast
cells, the relative inefficiency of enzymes responsible for histamine
inactivation, variations in the density of mast cell or H1 receptors, etc.
[3]; however, to our knowledge, this variability has not yet been
systematically investigated in a human model.
HSR does not appear to be a fixed parameter in humans: three
studies, in which cohorts of children aged 9 or 13 years were examined
in the same geographical setting at an interval of 13 or 16 years,
revealed a significant increase in HSR, which rose approximately 5-7%
per year [5,6]. As these studies were performed at the end of the last
century and have not been repeated since, it is impossible to know
whether this increase is a persisting trend.
One issue that is highly relevant to our discussion is the marked
inter-population variability in HSR. This finding first emerged from
the work conducted by Dreborg et al. [10], who found a significant
difference in histamine-induced wheals of small but thoroughly
studied populations from Berlin and Uppsala. Differences of HSR
between populations have been found by Riihjavik et al. [23] and by
von Mutius et al. [24]. Subsequently, in a large international
epidemiological study, we measured the skin wheals elicited by
histamine pricked at two concentrations in a total of approximately
800 unselected school children from Italy, Poland and Libya, and found
that HSR differed significantly in these three countries: the analysis of
the slopes of the regression lines for histamine concentrations in
relation to the wheal sizes demonstrated that the mean concentration
of injected histamine required to elicit a skin wheal of 3 mm in
diameter was 8.8 mg/ml in Libya, 29.5 mg/ml in Italy and 102.1 mg/ml
in Poland [11].
Interestingly, we found that these differences in HSR markedly
affected the amount of specific IgE required to produce a wheal of at
least 3 mm in an ASPT (the “atopic person” definition threshold). For
pricks performed with Dermatophagoides pteronyssinus, the amount
of IgE (in ku/l) was 1.25 in Libyan children, 11.51 (i.e. ten times
higher) in Polish children, and 3.47 in Italian children [11]. When we
subsequently subdivided all the children (regardless of nationality)
according to their HSR, we found that the amount of serum-specific
IgE required to induce a positive prick test was approximately eight
times higher (16.4 vs 2.2 ku/l for Dermatophagoides pteronyssinus) in
children with “”low” histamine skin reactivity (less than the 50th
percentile of the overall population) than in children with “high”
histamine skin reactivity (over the 50th percentile) [12]; the differences
between high and low histamine responders would have been
considerably greater had we compared subjects with this parameter
under the 10th percentile with those over the 90th percentile [12].
Comparable results have recently been reported by Dreborg et al.
who found, when they reanalyzed the data of the experiments
conducted in 1985 in Berlin and Uppsala, which the concentration of
allergen required to produce a certain skin wheal was 15 times higher
in the population that had significantly lower HSR (Berlin) [25].
The Clinical Meaning of Histamine Skin Reactivity
All the aforementioned data indicate that high HSR “produces”
larger or an increased number of positive ASPTs, because even a small
amount of specific IgE reacting with the appropriate antibody produces
an amount of histamine that is sufficient for a 3 mm wheal. This
interpretation may, however, also be inverted: allergen responsiveness
as measured by skin prick tests (atopic state) may result in increased
histamine skin sensitivity, a hypothesis backed by numerous authors.
For example, Stuckey et al. reported that allergen responsiveness is
related to high sensitivity to histamine (p< 0.001), an association that
is independent of IgE [26]. Van Gysell et al. [8] found that multiply-
sensitized children had significantly larger histamine-induced wheal
sizes than non-sensitized children. Yet other authors interpreted their
data in a comparable fashion [7,9,27].
There is also an intermediate position held by some authors who,
being fully aware of the existence of the two determinants of skin
wheal dimensions in ASPT (i.e. the amount of specific IgE and
“histamine skin sensitivity”), elaborated complex statistical methods
designed to remove the contribution of histamine skin reactivity and
hence to correct for the “observed wheal sizes” and avoid “atopy
misclassification” [28]. Obviously this approach is based on the
assumption that HSR is a “complication” (a disturbing component of
the wheal) in the clinical assessment of “true atopy” in patients.
In practice, we may agree that the implications of all the
aforementioned data and interpretations are identical: a 3 mm ASPT
wheal may be elicited in any individual (who would consequently be
classified as atopic) either by producing several ku of specific IgE per
litre of serum or by means of a high HSR.
Although these two extremes are combined in the vast majority of
patients, we may hypothesize the existence of two types of patients :
one type in whom “atopy“ is mainly the result of increased levels of
specific IgE antibodies, and another type in whom positive ASPRs are
mainly the result of a marked reactivity to even small amounts of
histamine. These distinctions are important on clinical grounds: when
we treat a patient whose clinical symptoms are generated above all by
exposure (through contact, ingestion or inhalation) to known antigens,
we find ourselves within a medical context whose study goes back
decades and whose underlying enemies we are generally aware of,
including the mechanisms of action, preventive strategies, effective
immunological and pharmaceutical therapies that need to be
undertaken. If we exclude cases suffering from severe poly-
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sensitization, we are confident that an effective treatment for such
patients is readily available.
The opposite is instead often true of patients in whom “atopy
“mainly depends on marked histamine reactivity. Current knowledge
of this biological characteristic is very limited and we are just
beginning to understand that this parameter is likely to be affected not
only by genetic but also environmental factors, as is clearly suggested
by the marked differences between countries and changes over time
within the same geographical setting.
Despite not yet being proven, it is reasonable to believe that hyper-
reactivity to histamine measured in the skin is the same as that in other
parts of the organism, particularly in all kinds of mucosae, in which
this hyper-reactivity is likely to be triggered by even a small increase in
histamine production, thereby causing symptoms such as oedema,
extravasation and muscle contraction, which tend to be chronic or
recurrent.
In the last decade a syndrome of “histamine intolerance”,
characterized by symptoms such as gastrointestinal disorders,
rhinorrhea and congestion of the nose, headache, urticaria, pruritus
and asthma, has been described and investigated [13]: its etiology is
complex and supposedly dependent on an imbalance between
histamine availability (production or ingestion) and its enzymatic
metabolic degradation. The possible connections between “histamine
intolerance” and increased “histamine skin reactivity” are evident.
“Histamine intolerance” is only one of the many syndromes recently
discussed in the literature that are characterized by recurrent or
chronic symptoms. The many other such syndromes include multiple
chemical sensitivities, chronic fatigue syndrome, fibromyalgia, chronic
hypoglycemia, irritable bowel syndrome, gulf war syndrome and sick
building syndrome [29]. Each of these clinical entities is the result of
efforts made by practitioners and investigators to label different groups
of patients that share a specific, though ill-defined, hyper-sensitivity
characterized by exposure to “irritating” environmental factors that
result in a range of chronic or recurrent groups of symptoms
(gastrointestinal, cutaneous, respiratory and neurological, particularly
headache) [30]. The etiology of these conditions not only tends to be
obscure or poorly defined, but the symptoms associated with each
largely overlap. Indeed, the number of labels that have been used to
describe them documents the remarkably high number of medical
encounters in which the symptoms reported by individuals do not fall
within standard medical conditions, or in which the clinical
examination does not correspond to any morphological or laboratory
findings.
Conclusion
We do not know whether the systematic measurement of HSR may
help to create a rational approach to these varied groups of patients.
We do, however, believe that an easily measured, clinically meaningful
biological parameter may contribute to our understanding of the wide
and slippery field of unexplained chronic or recurrent clinical
symptoms.
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